ASHIM DAYALAN: Open Payments
NPI 1376508028 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,846 in 181 payments from 35 companies in 2025. Trend: 2023 $3,411 · 2024 $4,208 · 2025 $3,846
Food & beverage: $3,846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $673 |
| Novo Nordisk Inc | 21 | $367 |
| AstraZeneca Pharmaceuticals LP | 12 | $314 |
| PFIZER INC. | 19 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $264 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $196 |
| GlaxoSmithKline, LLC. | 11 | $193 |
| Medtronic, Inc. | 4 | $191 |
| CeQur Corporation | 1 | $155 |
| Janssen Pharmaceuticals, Inc | 3 | $154 |
Products named: QULIPTA, CAPLYTA, AIRSUPRA, JARDIANCE, VRAYLAR, CeQur Simplicity, SPRAVATO, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
